ECC 2015: Rare Cancer Activities & Highlights

Three ECC 2015 sessions with a focus on rare cancers

Paediatric Oncology Society Session: European Society for Pediatric Oncology (SIOPE)

26 Sept 10:30-12:30
STOLZ 1

• Chair: G. Vassal (France) 
• Co-Chair: M. Schrappe (Germany)

10:30: Introduction of the session

• Speaker: M. Schrappe (Germany)

10:35: Presentation of the Lifetime Achievement Award

• Speaker: G. Vassal (France)

10:40: Lifetime Achievement Award Presentation

• Speaker: H.F. Jürgens (Germany)

10:55: Merit Award Presentation

Speaker: R. Hill (United Kingdom)

11:10: Future of paediatric oncology

• Speaker: G. Vassal (France)

11:35: Improving radiotherapy for children and adolescents

• Speaker: T. Boterberg (Belgium)

12:00: Maximising the opportunities from a very rare tumour portfolio: the siopel experience

• Speaker: B. Morland (United Kingdom)

12.25: Take home message

• Speaker: M. Schrappe (Germany) 

Oncopolicy Forum: Tackling Rare Cancers Requiring Specialist Care: European Reference Networks

28 Sept 17:00 - 18:30
HALL A3

• Chair: P.G. Casali (Italy)

17:15: The patient perspective

• Speaker: J. Geissler (Germany)

17:30: The research perspective: SPECTARARE

• Speaker: D. Lacombe (Belgium)

17:45: Spotlight on ERN in paediatric cancer: ExPO-r-Net

• Speaker: R. Ladenstein (Austria)

18:00: Views from the policy makers' perspective

• Speaker: T. Voigtlaender (Austria) 

Questions from the audience

Scientific Symposium: Bayesian, Adaptive and Rare Disease Designs

29 Sept 09:00 - 10:30
HALL A5

• Chair: U. Dafni (Greece)
• Co-Chair: B. Ryll (Sweden)

09:00: Design in rare disease: The oncologist perspective

• Speaker: P.G. Casali (Italy)

09:20: Implementing innovative trial design in small patient populations in childhood cancers

• Speaker: K. Wheatley (United Kingdom)

09:40: Pitfalls and advantages of using adaptive trial designs in phase III trials

• Speaker: M. Mauer (Belgium)

10:00: Multi-arm, multi-stage designs: Are they deliverable?

• Speaker: M. Parmar (United Kingdom)

Discussion & Roundup